Home Neuronal Signaling Beta Amyloid inhibitor - JNK inhibitor - NF-κB inhibitor Ginsenoside Re For research use only.

Ginsenoside Re

Synonyms: Panaxoside Re, Sanchinoside Re, Chikusetsusaponin Ivc

Ginsenoside Re (Ginsenoside B2, Panaxoside Re, Sanchinoside Re, Chikusetsusaponin Ivc), an extract from Panax notoginseng, is a major ginsenoside in ginseng and belongs to 20(S)-protopanaxatriol group. It has diverse in vitro and in vivo effects, including vasorelaxant, antioxidant, antihyperlipidemic, and angiogenic actions. Ginsenoside Re decreases the β-amyloid protein (Aβ). Ginsenoside Re plays a role in antiinflammation through inhibition of JNK and NF-κB.

Ginsenoside Re Chemical Structure

Ginsenoside Re Chemical Structure

CAS No. 52286-59-6

Purity & Quality Control

Ginsenoside Re Related Products

Signaling Pathway

Beta Amyloid Signaling Pathways

Beta Amyloid Signaling Pathway

Biological Activity

Description Ginsenoside Re (Ginsenoside B2, Panaxoside Re, Sanchinoside Re, Chikusetsusaponin Ivc), an extract from Panax notoginseng, is a major ginsenoside in ginseng and belongs to 20(S)-protopanaxatriol group. It has diverse in vitro and in vivo effects, including vasorelaxant, antioxidant, antihyperlipidemic, and angiogenic actions. Ginsenoside Re decreases the β-amyloid protein (Aβ). Ginsenoside Re plays a role in antiinflammation through inhibition of JNK and NF-κB.
Targets
Aβ [4] JNK [5] NF-κB [5]
In vitro
In vitro

Ginsenoside Re inhibits Ca2+ accumulation in mitochondria during cardiac ischemia/reperfusion, which is attributable to nitric oxide (NO)-induced Ca2+ channel inhibition and K+ channel activation in cardiac myocytes. Ginsenoside Re activates endothelial NO synthase (eNOS) to release NO, resulting in activation of the slowly activating delayed rectifier K+ current. However, ginsenoside Re does not stimulate proliferation of androgen-responsive LNCaP cells and estrogen-responsive MCF-7 cells, implying that ginsenoside Re does not activate a genomic pathway of sex hormone receptors. ginsenoside Re induces phosphorylation of Akt in cardiomyocytes in a concentration-dependent manner. Ginsenoside Re is a partial agonist of the AR, ERα, and PR. It is a partial antagonist, but not an agonist, of the genomic pathway of AR or ERα[1].
Cell Research Cell lines MCF-7 and LNCaP cells
Concentrations 10 μM
Incubation Time 5 days
Method

Cells are seeded in triplicate at a density of 1.6 × 105 cells/ml in phenolred-free DMEM/F12 with 10% charcoal-treated fetal bovine serum. Five days after cells have been incubated in the presence of 17β-estradiol (E2; 10 nM), 5α-dihydrotestosterone (DHT; 10 nM), or ginsenoside Re (10 μM), they are collected and cell numbers are counted.
In Vivo
In vivo

The absorption of Re is fast in gastrointestinal tract. Re may be metabolized mainly to Rh1 and F1 by intestinal microflora before absorption into blood; and Re is quickly cleared from the body. In cardiovascular system, Re possesses negative effects on cardiac contractility and autorhythmicity, anti-arrhythmic and anti-ischemic effects, angiogenic regeneration activities and cardiac electrophysiological functions. Re reaches peak concentration in plasma within about 45 minutes after oral administration of total panax notoginsenoside (TPNG) powder in rats, suggesting a rapid absorption in gastrointestinal tract. The absolute bioavailability of Re is 7.06%. In pharmacokinetic study using ICR mice, the time to reach the peak plasma concentration after oral administration is 0.4 ± 0.2 hour and the oral bioavailability is 0.19-0.28%. Re is rapidly cleared from the body within 0.2 ± 0.03 hour for male mice and 0.5 ± 0.08 hour for female mice after intravenous administration[2]. Re administration in ob/ob mice significantly reduces fasting blood glucose levels, improves glucose tolerance and systemic insulin sensitivity without affecting body weight. These events are mediated, at least in part, by the changes in skeletal muscle gene expression[3].
Animal Research Animal Models Adult male C57BL/6J ob/ob mice
Dosages 7, 20 and 60 mg/kg
Administration i.p.

Chemical Information & Solubility

Molecular Weight 947.15 Formula

C48H82O18
CAS No. 52286-59-6 SDF Download Ginsenoside Re SDF
Smiles CC1C(C(C(C(O1)OC2C(C(C(OC2OC3CC4(C(CC(C5C4(CCC5C(C)(CCC=C(C)C)OC6C(C(C(C(O6)CO)O)O)O)C)O)C7(C3C(C(CC7)O)(C)C)C)C)CO)O)O)O)O)O
Storage (From the date of receipt)

In vitro
Batch:

DMSO : 100 mg/mL ( (105.57 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Ethanol : 20 mg/mL

Water : Insoluble


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Ginsenoside Re | Ginsenoside Re supplier | purchase Ginsenoside Re | Ginsenoside Re cost | Ginsenoside Re manufacturer | order Ginsenoside Re | Ginsenoside Re distributor